Nonmelanoma skin cancer and risk for subsequent malignancy
- PMID: 18728282
- PMCID: PMC2720713
- DOI: 10.1093/jnci/djn260
Nonmelanoma skin cancer and risk for subsequent malignancy
Abstract
Background: Individuals with a personal history of nonmelanoma skin cancer (NMSC) may have an increased risk of subsequent noncutaneous malignancies. To test this hypothesis, we carried out a community-based, prospective cohort study.
Methods: In the CLUE (Give Us a Clue to Cancer and Heart Disease) II cohort, which was established in Washington County, MD, in 1989, the risk of new malignancies was compared among individuals with (n = 769) and without (n = 18,405) a personal history of NMSC (total n = 19,174) during a 16-year follow-up period. Pathologically confirmed NMSC (and other malignancies) were ascertained from the Washington County Cancer Registry. Cox regression analysis with time-dependent covariates was used to determine the hazard ratios (presented as multivariable-adjusted relative risks [RRs]) and 95% confidence intervals (CIs) of second primary malignancies associated with a previously confirmed NMSC diagnosis. All statistical tests were two-sided.
Results: The crude incidence rate (per 10,000 person-years) of subsequent cancers other than NMSC among participants with a positive personal history of NMSC was 293.5 and with a negative history was 77.8. Compared with persons with no personal history of NMSC, those with such a history had a statistically significantly increased risk of being diagnosed with a subsequent cancer other than NMSC (RR = 1.99, 95% CI = 1.70 to 2.33) after adjusting for age, sex, body mass index, smoking status, and educational level. The association was observed for both basal cell carcinoma (multivariable-adjusted RR = 2.03, 95% CI = 1.70 to 2.42) and squamous cell carcinoma (multivariable-adjusted RR = 1.97, 95% CI = 1.50 to 2.59) of the skin. NMSC was a statistically significantly stronger cancer risk factor in younger age groups than in older age groups (P for interaction = .022).
Conclusions: This community-based, prospective cohort study provides evidence for an association between an NMSC diagnosis and an increased risk of subsequent cancer, even after adjusting for individual-level risk factors.
Comment in
-
Re: Nonmelanoma skin cancer and risk for subsequent malignancy.J Natl Cancer Inst. 2009 Feb 4;101(3):210; author reply 210-1. doi: 10.1093/jnci/djn465. Epub 2009 Jan 27. J Natl Cancer Inst. 2009. PMID: 19176462 No abstract available.
References
-
- American Cancer Society. Cancer Facts and Figures 2007. Atlanta: American Cancer Society; 2007.
-
- Scotto J, Fears TR, Kraemer KH, Fraumeni JF., Jr. Nonmelanoma skin cancer. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer Epidemiology and Prevention. 2nd ed. New York: Oxford University Press; 1996. Chapter 60.
-
- Chen JG, Fleischer AB, Smith ED, et al. Cost of nonmelanoma skin cancer treatment in the United States. Dermatol Surg. 2001;27(12):1035–1038. - PubMed
-
- Scotto J, Fears TR, Fraumeni JF., Jr. Solar radiation. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer Epidemiology and Prevention. 2nd ed. New York: Oxford University Press; 1996. Chapter 17.
-
- Habif TP. Clinical Dermatology. In: Habif TP, editor. Premalignant and Malignant Nonmelanoma Skin Tumors. 4th ed. Philadelphia, PA: Mosby; 2004. Chapter 21.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
